Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Generative AI in Clinical Trial Market 2025-2029" has been added to ResearchAndMarkets.com's offering.
The generative AI in clinical trial market is poised for substantial growth, with projections estimating an increase of USD 572.7 million between 2024 and 2029, achieving a CAGR of 30.8% within the forecast period. The comprehensive market report provides an in-depth analysis, offering insights into market size, trends, growth drivers, challenges, and a vendor analysis encompassing around 25 key players.
The current market landscape highlights the necessity to reduce clinical development costs and timelines, manage the increasing complexity of trials, and handle the proliferation of multimodal data. Rapid technological advancements coupled with strategic cross-industry collaborations are significant growth drivers.
A notable trend accelerating market growth is the rise of domain-specific and multimodal generative models. The increasing prominence of the AI-as-a-service ecosystem, deep platform integration, and a transformative shift from pure automation to human augmentation are expected to generate significant demand.
The report amalgamates primary and secondary information, supported by contributions from industry experts, to deliver a holistic view of the market. It includes historical data, forecasts, regional analysis, and an elaborate vendor landscape evaluation, offering valuable insights into key industry players.
Market Segmentation
By Deployment:
- Cloud-based
- On-premises
By Application:
- Trial design optimization
- Data management and analysis
- Patient recruitment
- Adverse event prediction and detection
- Regulatory compliance
By End-user:
- Pharma and biotech companies
- Contract research organizations
- Others
By Geographical Landscape:
- North America
- Europe
- APAC
- South America
- Middle East and Africa
Report Coverage:
- Market sizing and forecast
- Industry analysis
Emphasizing vendor analysis, the report offers strategic insights for enhancing market positioning. It evaluates leading vendors such as A.I. VALI Inc., Acclinate Inc., AiCure, and Antidote Technologies Inc., among others. Furthermore, the report delves into emerging trends and potential challenges that could impact market growth, aiding companies in strategizing and capitalizing on growth opportunities.
The report synthesizes data from multiple sources, analyzing key parameters like profit, pricing, and competition. It offers a comprehensive and reliable market perspective, grounded in extensive research efforts.
A selection of companies mentioned in this report includes, but is not limited to:
- A.I. VALI Inc.
- Acclinate Inc.
- AiCure
- Antidote Technologies Inc.
- Claritrics Inc.
- ConcertAI Inc.
- Deep 6 AI Inc.
- Exscientia plc
- Innoplexus
- Intelligencia Inc.
- Median Technologies SA
- Medidata
- Opyl Ltd.
- Owkin Inc.
- SiteRx Inc.
- Tempus Labs Inc.
- Trials.ai
- Unlearn.ai Inc.
For more information about this report visit https://www.researchandmarkets.com/r/2bdyp2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
